Importantly, 6 days after transfer into tumor-free T/B/NK cell-deficient NSG mice (supplemented daily with IL-2), IL-12/15/18 pre-activated NK cells were superior in IFN-γ production when restimulated ex vivo with K562 cells or cytokines (24, 42, 44). The gene discussed is IL2; the disease is neoplasm.